Zdrowie i gospodarka · 21/03/2022

FDA Requests Public Comment on Proposed Collection of Information for Enhanced Review Transparency and Communication

The Food and Drug Administration is seeking public input on its proposed collection of information for evaluating new molecular entity new drug applications and original biologics license applications, as part of its Enhanced Review Transparency and Communication program.